Literature DB >> 11246493

The demonstration by transplantation of the very restricted remyelinating potential of post-mitotic oligodendrocytes.

A J Crang1, J Gilson, W F Blakemore.   

Abstract

To examine the remyelinating ability of post-mitotic oligodendrocytes, we subjected cell preparations derived from neonatal and adult rats to 40 Grays of X-irradiation to remove mitotically active cells and injected them into areas of demyelination in which the inherent ability to generate remyelinating cells had been inhibited. The extensive remyelination seen following implantation of non-irradiated neonatal and adult cells was almost completely abolished when the transplanted cell suspension was exposed to 40 Grays of X-irradiation, demonstrating that effective remyelination requires the generation of cells by mitosis. Radiation-resistant and therefore non-dividing oligodendrocytes were detected in areas of demyelination following transplantation of neonatal cultures and oligodendrocyte preparations derived from the adult nervous system. However, the pattern of myelin formation associated with the radiation-resistant oligodendrocytes from the two sources was different. Following implantation of X-irradiated neonatal cultures, a small number of oligodendrocytes could be found within the area of demyelination, and although these cells formed sheets of myelin membrane, they did not form myelin sheaths. After implantation of X-irradiated adult cells, in addition to the aberrant myelin formation seen with the neonatal cells, some myelin sheaths were observed. Our findings confirm that effective remyelination requires cell division and suggest that there may be diverse populations of radiation-resistant oligodendrocytes in the adult nervous system, some of which can form myelin sheaths and others of which can only make myelin sheets. Important for the interpretation of our previous studies is the demonstration here that 40 Grays of X-irradiation per se does not inhibit oligodendrocytes from remyelinating axons.

Entities:  

Mesh:

Year:  1998        PMID: 11246493     DOI: 10.1023/a:1006960032023

Source DB:  PubMed          Journal:  J Neurocytol        ISSN: 0300-4864


  9 in total

Review 1.  Cell therapy for multiple sclerosis.

Authors:  Tamir Ben-Hur
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

2.  Remyelination reporter reveals prolonged refinement of spontaneously regenerated myelin.

Authors:  Berit E Powers; Drew L Sellers; Emilie A Lovelett; Willy Cheung; Sheida P Aalami; Nikolai Zapertov; Don O Maris; Philip J Horner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

3.  Cellular compensatory mechanisms in the CNS of dysmyelinated rats.

Authors:  Jacek M Kwiecien
Journal:  Comp Med       Date:  2010-06       Impact factor: 0.982

4.  Differing in vitro survival dependency of mouse and rat NG2+ oligodendroglial progenitor cells.

Authors:  Makoto Horiuchi; Tullia Lindsten; David Pleasure; Takayuki Itoh
Journal:  J Neurosci Res       Date:  2010-04       Impact factor: 4.164

5.  Distinct stages of myelination regulated by gamma-secretase and astrocytes in a rapidly myelinating CNS coculture system.

Authors:  Trent A Watkins; Ben Emery; Sara Mulinyawe; Ben A Barres
Journal:  Neuron       Date:  2008-11-26       Impact factor: 17.173

Review 6.  Precursor cell biology and the development of astrocyte transplantation therapies: lessons from spinal cord injury.

Authors:  Mark Noble; Jeannette E Davies; Margot Mayer-Pröschel; Christoph Pröschel; Stephen J A Davies
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

Review 7.  What roles do growth factors play in CNS remyelination?

Authors:  R J Franklin; G L Hinks; R H Woodruff; M T O'Leary
Journal:  Prog Brain Res       Date:  2001       Impact factor: 2.453

8.  Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells.

Authors:  Fadi J Najm; Angela M Lager; Anita Zaremba; Krysta Wyatt; Andrew V Caprariello; Daniel C Factor; Robert T Karl; Tadao Maeda; Robert H Miller; Paul J Tesar
Journal:  Nat Biotechnol       Date:  2013-04-14       Impact factor: 54.908

9.  Accelerated repair of demyelinated CNS lesions in the absence of non-muscle myosin IIB.

Authors:  Tomasz Rusielewicz; Jennifer Nam; Evangelos Damanakis; Gareth R John; Cedric S Raine; Carmen V Melendez-Vasquez
Journal:  Glia       Date:  2014-01-28       Impact factor: 7.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.